Literature DB >> 27605712

Long-Term Rasamsonia argillacea Complex Species Colonization Revealed by PCR Amplification of Repetitive DNA Sequences in Cystic Fibrosis Patients.

Abdelmounaim Mouhajir1,2, Olivier Matray3,4, Sandrine Giraud1, Laurent Mély5, Christophe Marguet6, Isabelle Sermet-Gaudelus7, Solène Le Gal1,8, Franck Labbé9, Christine Person10, Françoise Troussier11, Jean-Jacques Ballet3, Gilles Gargala3,4, Rachid Zouhair2, Marie-Elisabeth Bougnoux12, Jean-Philippe Bouchara1,13, Loïc Favennec14,4.   

Abstract

The aim of this work was to document molecular epidemiology of Rasamsonia argillacea species complex isolates from cystic fibrosis (CF) patients. In this work, 116 isolates belonging to this species complex and collected from 26 CF patients and one patient with chronic granulomatous disease were characterized using PCR amplification assays of repetitive DNA sequences and electrophoretic separation of amplicons (rep-PCR). Data revealed a clustering consistent with molecular species identification. A single species was recovered from most patients. Rasamsonia aegroticola was the most common species, followed by R. argillacea sensu stricto and R. piperina, while R. eburnea was not identified. Of 29 genotypes, 7 were shared by distinct patients while 22 were patient specific. In each clinical sample, most isolates exhibited an identical genotype. Genotyping of isolates recovered from sequential samples from the same patient confirmed the capability of R. aegroticola and R. argillacea isolates to chronically colonize the airways. A unique genotype was recovered from two siblings during a 6-month period. In the other cases, a largely dominant genotype was detected. Present results which support the use of rep-PCR for both identification and genotyping for the R. argillacea species complex provide the first molecular evidence of chronic airway colonization by these fungi in CF patients.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27605712      PMCID: PMC5078560          DOI: 10.1128/JCM.01462-16

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  40 in total

1.  MALDI-TOF MS proteomic phenotyping of filamentous and other fungi from clinical origin.

Authors:  Federica Del Chierico; Andrea Masotti; Manuela Onori; Ersilia Fiscarelli; Livia Mancinelli; Gabriella Ricciotti; Federico Alghisi; Leopoldo Dimiziani; Cesare Manetti; Andrea Urbani; Maurizio Muraca; Lorenza Putignani
Journal:  J Proteomics       Date:  2012-04-04       Impact factor: 4.044

2.  Sputum Candida albicans presages FEV₁ decline and hospital-treated exacerbations in cystic fibrosis.

Authors:  Sanjay H Chotirmall; Elaine O'Donoghue; Kathleen Bennett; Cedric Gunaratnam; Shane J O'Neill; Noel G McElvaney
Journal:  Chest       Date:  2010-05-14       Impact factor: 9.410

3.  Disseminated Geosmithia argillacea infection in a German shepherd dog.

Authors:  David C Grant; Deanna A Sutton; Christina A Sandberg; Ronald D Tyler; Elizabeth H Thompson; Anna M Romanelli; Brian L Wickes
Journal:  Med Mycol       Date:  2009-03       Impact factor: 4.076

4.  Disseminated Geosmithia argillacea infection in a patient with gastrointestinal GvHD.

Authors:  T Valentin; P Neumeister; M Pichler; A Rohn; C Koidl; D Haas; B Heiling; M Asslaber; I Zollner-Schwetz; M Hoenigl; H J F Salzer; R Krause; W Buzina
Journal:  Bone Marrow Transplant       Date:  2011-07-25       Impact factor: 5.483

5.  Chronic airway colonization by Penicillium emersonii in a patient with cystic fibrosis.

Authors:  B Cimon; J Carrere; J P Chazalette; J F Vinatier; D Chabasse; J P Bouchara
Journal:  Med Mycol       Date:  1999-08       Impact factor: 4.076

6.  Use of random amplified polymorphic DNA PCR to examine epidemiology of Stenotrophomonas maltophilia and Achromobacter (Alcaligenes) xylosoxidans from patients with cystic fibrosis.

Authors:  J W Krzewinski; C D Nguyen; J M Foster; J L Burns
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

7.  Geosmithia argillacea: an emerging pathogen in patients with cystic fibrosis.

Authors:  Sandrine Giraud; Marc Pihet; Bienvenue Razafimandimby; Jacqueline Carrère; Nicolas Degand; Laurent Mely; Loïc Favennec; Eric Dannaoui; Jean-Philippe Bouchara; Alphonse Calenda
Journal:  J Clin Microbiol       Date:  2010-05-12       Impact factor: 5.948

8.  Taxonomy and antifungal susceptibility of clinically important Rasamsonia species.

Authors:  J Houbraken; S Giraud; M Meijer; S Bertout; J C Frisvad; J F Meis; J P Bouchara; R A Samson
Journal:  J Clin Microbiol       Date:  2012-10-17       Impact factor: 5.948

9.  Exchange of Pseudomonas aeruginosa strains among cystic fibrosis siblings.

Authors:  N H Renders; M A Sijmons; A van Belkum; S E Overbeek; J W Mouton; H A Verbrugh
Journal:  Res Microbiol       Date:  1997-06       Impact factor: 3.992

10.  Clinical and microbiological efficacy of micafungin on Geosmithia argillacea infection in a cystic fibrosis patient.

Authors:  Christophe Marguet; Loïc Favennec; Olivier Matray; Sébastien Bertout; Sandrine Giraud; Laure Couderc; Rachid Zouhair; Christine Leguillon; Gilles Gargala; Jean-J Jacques Ballet; Jean-Philippe Bouchara
Journal:  Med Mycol Case Rep       Date:  2012-09-12
View more
  2 in total

1.  Challenges in Laboratory Detection of Fungal Pathogens in the Airways of Cystic Fibrosis Patients.

Authors:  Sharon C-A Chen; Wieland Meyer; Catherine H Pashley
Journal:  Mycopathologia       Date:  2017-06-06       Impact factor: 2.574

Review 2.  Cystic fibrosis lung environment and Pseudomonas aeruginosa infection.

Authors:  Anjali Y Bhagirath; Yanqi Li; Deepti Somayajula; Maryam Dadashi; Sara Badr; Kangmin Duan
Journal:  BMC Pulm Med       Date:  2016-12-05       Impact factor: 3.317

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.